|
| Status |
Public on Feb 14, 2019 |
| Title |
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
30538293 |
| Submission date |
Feb 22, 2017 |
| Last update date |
Jun 04, 2019 |
| Contact name |
Shana Claeys |
| Organization name |
Center for Medical Genetics Ghent
|
| Street address |
De Pintelaan 185
|
| City |
Ghent |
| ZIP/Postal code |
9000 |
| Country |
Belgium |
| |
|
| Platforms (2) |
| GPL14550 |
Agilent-028004 SurePrint G3 Human GE 8x60K Microarray (Probe Name Version) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (16)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE94811 |
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [microarray] |
| GSE95189 |
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] |
|
| Relations |
| BioProject |
PRJNA376388 |
Less...
More...